Cargando…

The mononuclear phagocyte system in hepatocellular carcinoma

The mononuclear phagocyte system (MPS) consists of monocytes, dendritic cells and macrophages, which play vital roles in innate immune defense against cancer. Hepatocellular carcinoma (HCC) is a complex disease that is affected or initiated by many factors, including chronic hepatitis B virus infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Duan-Rui, Shan, Guan-Yue, Wang, Shuai, Cheng, Jun-Ya, Yan, Wei-Qun, Li, Hai-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753057/ https://www.ncbi.nlm.nih.gov/pubmed/36533105 http://dx.doi.org/10.3748/wjg.v28.i45.6345

Ejemplares similares

Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2022)

MIF is a critical regulator of mononuclear phagocytic infiltration in hepatocellular carcinoma
por: Liao, Yunxi, et al.
Publicado: (2023)

Systemic treatment for unresectable hepatocellular carcinoma
por: Leowattana, Wattana, et al.
Publicado: (2023)

Influence of the acute alcoholism on the phagocytic function of the mononuclear phagocytic system
por: Sabino, KR, et al.
Publicado: (2011)

Ablative strategies for recurrent hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2023)

Biomarkers for hepatocellular carcinoma based on body fluids and feces
por: Guan, Ming-Cheng, et al.
Publicado: (2021)

The Mononuclear Phagocytic System. Generation of Diversity
por: Gordon, Siamon, et al.
Publicado: (2019)

Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy
por: Zhang, Chun-Ye, et al.
Publicado: (2022)

The Role of Mononuclear Phagocytes in the Testes and Epididymis
por: Shi, Xu, et al.
Publicado: (2022)

Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
por: Luo, Yi, et al.
Publicado: (2022)

Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors
por: Piñero, Federico, et al.
Publicado: (2020)

Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
por: Silk, Tarik, et al.
Publicado: (2022)

Editorial: The Mononuclear Phagocyte System in Infectious Disease
por: Lugo-Villarino, Geanncarlo, et al.
Publicado: (2019)

Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
por: Sho, Takuya, et al.
Publicado: (2021)

Mononuclear phagocytes in head and neck squamous cell carcinoma
por: Kross, Kenneth Wilfried, et al.
Publicado: (2009)

THE ORIGIN AND KINETICS OF MONONUCLEAR PHAGOCYTES
por: van Furth, Ralph, et al.
Publicado: (1968)

Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

Recent update on comprehensive therapy for advanced hepatocellular carcinoma
por: Wang, Hui, et al.
Publicado: (2021)

Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
por: Li, Jiang, et al.
Publicado: (2023)

Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
por: Lu, Ren-Cai, et al.
Publicado: (2019)

Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
por: Hsu, Che-Yu, et al.
Publicado: (2019)

Management of centrally located hepatocellular carcinoma: Update 2016
por: Yu, Wei-Bo, et al.
Publicado: (2017)

Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009)

Dimensions of hepatocellular carcinoma phenotypic diversity
por: Désert, Romain, et al.
Publicado: (2018)

Hepatocellular carcinoma – time to take the ticket
por: Mullath, Anju, et al.
Publicado: (2019)

Update on hepatocellular carcinoma: Pathologists’ review
por: El Jabbour, Tony, et al.
Publicado: (2019)

Characterization of metabolic landscape in hepatocellular carcinoma
por: Wu, Jing, et al.
Publicado: (2021)

Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022)

Targets of immunotherapy for hepatocellular carcinoma: An update
por: Rai, Vikrant, et al.
Publicado: (2022)

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)

From the Reticuloendothelial to Mononuclear Phagocyte System – The Unaccounted Years
por: Yona, Simon, et al.
Publicado: (2015)

Reinforcing the Functionality of Mononuclear Phagocyte System to Control Tuberculosis
por: Pahari, Susanta, et al.
Publicado: (2018)

Mononuclear phagocyte system in hepatitis C virus infection
por: Yang, Yu, et al.
Publicado: (2018)

Friends or foes: The mononuclear phagocyte system in ischemic stroke
por: Ziqing, Zhang, et al.
Publicado: (2023)

Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2022)

Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
por: Cong, Rong, et al.
Publicado: (2023)

Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium
por: Wan, Zhuo, et al.
Publicado: (2020)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance: An evidence-based approach
por: Harris, Patrick S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u53sad6mg8m5mu9tq6f3e2r832